SHR-2005
- Generic Name
- SHR-2005
A Phase I Clinical Study of SHR-2005 Intravesical Instillation in the Treatment of Intermediate and High-risk Non-muscle Invasive Bladder Cancer (NMIBC)
Phase 1
Recruiting
- Conditions
- Intermediate and High-risk Non-muscle Invasive Bladder Cancer
- Interventions
- First Posted Date
- 2023-10-31
- Last Posted Date
- 2024-12-03
- Lead Sponsor
- Shanghai Hengrui Pharmaceutical Co., Ltd.
- Target Recruit Count
- 170
- Registration Number
- NCT06108492
- Locations
- 🇨🇳
Fudan University Zhongshan Hospital, Shanghai, Shanghai, China
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath